10-Q Filing

IDEXX LABORATORIES INC /DE CIK: 874716 Q1 2018

Filing Information

Form Type	10-Q
Accession Number	`0000874716-18-000008`
Period End Date	20180331
Filing Date	20180504
Fiscal Year	2018
Fiscal Period	Q1
XBRL Instance	idxx-20180331.xml

Filing Contents

This filing contains the following financial statements:

Balance Sheet 81 Income Statement 40 Cash Flow Statement 53 Comprehensive Income 28

Balance Sheet 81 line items

Line Item	Tag	Value	Unit	Period
Accounts receivable, reserves	`AllowanceForDoubtfulAccountsReceivableCurrent`	$4.81M	USD	Point-in-time
Accounts receivable, reserves	`AllowanceForDoubtfulAccountsReceivableCurrent`	$4.58M	USD	Point-in-time
Common stock, par value	`CommonStockParOrStatedValuePerShare`	$0.10	USD	Point-in-time
Common stock, par value	`CommonStockParOrStatedValuePerShare`	$0.10	USD	Point-in-time
Common stock, shares authorized	`CommonStockSharesAuthorized`	120.00M	shares	Point-in-time
Common stock, shares authorized	`CommonStockSharesAuthorized`	120.00M	shares	Point-in-time
Cash and cash equivalents	`CashAndCashEquivalentsAtCarryingValue`	$187.68M	USD	Point-in-time
Cash and cash equivalents	`CashAndCashEquivalentsAtCarryingValue`	$159.23M	USD	Point-in-time
Common stock, shares issued	`CommonStockSharesIssued`	104.68M	shares	Point-in-time
Common stock, shares issued	`CommonStockSharesIssued`	104.28M	shares	Point-in-time
Marketable securities	`AvailableForSaleSecuritiesDebtSecuritiesCurrent`	$284.25M	USD	Point-in-time
Common stock, shares, outstanding	`CommonStockSharesOutstanding`	87.00M	shares	Point-in-time
Accounts receivable, net of reserves of $4,808 in 2018 and $4,576 in 2017	`AccountsReceivableNetCurrent`	$234.60M	USD	Point-in-time
Common stock, shares, outstanding	`CommonStockSharesOutstanding`	87.10M	shares	Point-in-time
Accounts receivable, net of reserves of $4,808 in 2018 and $4,576 in 2017	`AccountsReceivableNetCurrent`	$259.87M	USD	Point-in-time
Inventories	`InventoryNet`	$164.32M	USD	Point-in-time
Deferred stock units, outstanding	`CommonStockOtherSharesOutstanding`	229,000.00	shares	Point-in-time
Deferred stock units, outstanding	`CommonStockOtherSharesOutstanding`	217,000.00	shares	Point-in-time
Inventories	`InventoryNet`	$179.04M	USD	Point-in-time
Treasury stock, shares	`TreasuryStockShares`	17.17M	shares	Point-in-time
Other current assets	`OtherAssetsCurrent`	$103.57M	USD	Point-in-time
Other current assets	`OtherAssetsCurrent`	$101.14M	USD	Point-in-time
Treasury stock, shares	`TreasuryStockShares`	17.68M	shares	Point-in-time
Total current assets	`AssetsCurrent`	$971.99M	USD	Point-in-time
Total current assets	`AssetsCurrent`	$701.71M	USD	Point-in-time
Property and equipment, net	`PropertyPlantAndEquipmentNet`	$379.10M	USD	Point-in-time
Property and equipment, net	`PropertyPlantAndEquipmentNet`	$384.25M	USD	Point-in-time
Goodwill	`Goodwill`	$201.02M	USD	Point-in-time
Goodwill	`Goodwill`	$199.87M	USD	Point-in-time
Intangible assets, net	`IntangibleAssetsNetExcludingGoodwill`	$43.85M	USD	Point-in-time
Intangible assets, net	`IntangibleAssetsNetExcludingGoodwill`	$41.89M	USD	Point-in-time
Other long-term assets	`OtherAssetsNoncurrent`	$118.62M	USD	Point-in-time
Other long-term assets	`OtherAssetsNoncurrent`	$140.62M	USD	Point-in-time
Total long-term assets	`AssetsNoncurrent`	$767.78M	USD	Point-in-time
Total long-term assets	`AssetsNoncurrent`	$741.43M	USD	Point-in-time
TOTAL ASSETS	`Assets`	$1.71B	USD	Point-in-time
TOTAL ASSETS	`Assets`	$1.47B	USD	Point-in-time
Accounts payable	`AccountsPayableCurrent`	$70.41M	USD	Point-in-time
Accounts payable	`AccountsPayableCurrent`	$66.97M	USD	Point-in-time
Accrued liabilities	`AccruedLiabilitiesCurrent`	$210.38M	USD	Point-in-time
Accrued liabilities	`AccruedLiabilitiesCurrent`	$253.42M	USD	Point-in-time
Line of credit	`LinesOfCreditCurrent`	$407.50M	USD	Point-in-time
Line of credit	`LinesOfCreditCurrent`	$655.00M	USD	Point-in-time
Current portion of deferred revenue	`DeferredRevenueCurrent`	$29.18M	USD	Point-in-time
Current portion of deferred revenue	`DeferredRevenueCurrent`	$40.55M	USD	Point-in-time
Total current liabilities	`LiabilitiesCurrent`	$728.84M	USD	Point-in-time
Total current liabilities	`LiabilitiesCurrent`	$1.00B	USD	Point-in-time
Deferred income tax liabilities	`DeferredTaxLiabilitiesNoncurrent`	$25.35M	USD	Point-in-time
Deferred income tax liabilities	`DeferredTaxLiabilitiesNoncurrent`	$27.53M	USD	Point-in-time
Long-term debt	`SecuredLongTermDebt`	$606.08M	USD	Point-in-time
Long-term debt	`SecuredLongTermDebt`	$609.00M	USD	Point-in-time
Long-term deferred revenue, net of current portion	`DeferredRevenueNoncurrent`	$35.55M	USD	Point-in-time
Long-term deferred revenue, net of current portion	`DeferredRevenueNoncurrent`	$68.53M	USD	Point-in-time
Other long-term liabilities	`OtherLiabilitiesNoncurrent`	$84.57M	USD	Point-in-time
Other long-term liabilities	`OtherLiabilitiesNoncurrent`	$95.72M	USD	Point-in-time
Total long-term liabilities	`LiabilitiesNoncurrent`	$762.69M	USD	Point-in-time
Total long-term liabilities	`LiabilitiesNoncurrent`	$789.64M	USD	Point-in-time
Total liabilities	`Liabilities`	$1.52B	USD	Point-in-time
Total liabilities	`Liabilities`	$1.77B	USD	Point-in-time
Commitments and Contingencies (Note 14)	`CommitmentsAndContingencies`	-	USD	Point-in-time
Commitments and Contingencies (Note 14)	`CommitmentsAndContingencies`	-	USD	Point-in-time
Common stock, $0.10 par value: Authorized: 120,000 shares; Issued: 104,676 shares in 2018 and 104,275 shares in 2017; Outstanding: 86,997 shares in 2018 and 87,104 shares in 2017	`CommonStockValue`	$10.43M	USD	Point-in-time
Common stock, $0.10 par value: Authorized: 120,000 shares; Issued: 104,676 shares in 2018 and 104,275 shares in 2017; Outstanding: 86,997 shares in 2018 and 87,104 shares in 2017	`CommonStockValue`	$10.47M	USD	Point-in-time
Additional paid-in capital	`AdditionalPaidInCapitalCommonStock`	$1.09B	USD	Point-in-time
Additional paid-in capital	`AdditionalPaidInCapitalCommonStock`	$1.07B	USD	Point-in-time
Deferred stock units: Outstanding: 217 units in 2018 and 229 units in 2017	`CommonStockOtherValueOutstanding`	$5.77M	USD	Point-in-time
Deferred stock units: Outstanding: 217 units in 2018 and 229 units in 2017	`CommonStockOtherValueOutstanding`	$5.99M	USD	Point-in-time
Retained earnings	`RetainedEarningsAccumulatedDeficit`	$803.54M	USD	Point-in-time
Retained earnings	`RetainedEarningsAccumulatedDeficit`	$880.35M	USD	Point-in-time
Accumulated other comprehensive loss	`AccumulatedOtherComprehensiveIncomeLossNetOfTax`	$-36.47M	USD	Point-in-time
Accumulated other comprehensive loss	`AccumulatedOtherComprehensiveIncomeLossNetOfTax`	$-34.21M	USD	Point-in-time
Treasury stock, at cost: 17,679 shares in 2018 and 17,171 shares in 2017	`TreasuryStockValue`	$1.91B	USD	Point-in-time
Treasury stock, at cost: 17,679 shares in 2018 and 17,171 shares in 2017	`TreasuryStockValue`	$2.01B	USD	Point-in-time
Total IDEXX Laboratories, Inc. stockholders deficit	`StockholdersEquity`	$-49.27M	USD	Point-in-time
Total IDEXX Laboratories, Inc. stockholders deficit	`StockholdersEquity`	$-54.11M	USD	Point-in-time
Noncontrolling interest	`MinorityInterest`	$264.00K	USD	Point-in-time
Noncontrolling interest	`MinorityInterest`	$290.00K	USD	Point-in-time
Total stockholders deficit	`StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest`	$-48.98M	USD	Point-in-time
Total stockholders deficit	`StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest`	$-53.84M	USD	Point-in-time
TOTAL LIABILITIES AND STOCKHOLDERS DEFICIT	`LiabilitiesAndStockholdersEquity`	$1.71B	USD	Point-in-time
TOTAL LIABILITIES AND STOCKHOLDERS DEFICIT	`LiabilitiesAndStockholdersEquity`	$1.47B	USD	Point-in-time

Income Statement 40 line items

Line Item	Tag	Value	Unit	Period
Total revenue	`RevenueFromContractWithCustomerExcludingAssessedTax`	$537.66M	USD	1 Quarter
Total revenue	`RevenueFromContractWithCustomerExcludingAssessedTax`	$462.02M	USD	1 Quarter
Cost of product revenue	`CostOfGoodsSold`	$103.03M	USD	1 Quarter
Cost of product revenue	`CostOfGoodsSold`	$118.25M	USD	1 Quarter
Cost of service revenue	`CostOfServices`	$116.31M	USD	1 Quarter
Cost of service revenue	`CostOfServices`	$100.80M	USD	1 Quarter
Total cost of revenue	`CostOfRevenue`	$234.56M	USD	1 Quarter
Total cost of revenue	`CostOfRevenue`	$203.83M	USD	1 Quarter
Gross profit	`GrossProfit`	$258.19M	USD	1 Quarter
Gross profit	`GrossProfit`	$303.10M	USD	1 Quarter
Sales and marketing	`SellingAndMarketingExpense`	$87.24M	USD	1 Quarter
Sales and marketing	`SellingAndMarketingExpense`	$100.10M	USD	1 Quarter
General and administrative	`GeneralAndAdministrativeExpense`	$52.91M	USD	1 Quarter
General and administrative	`GeneralAndAdministrativeExpense`	$60.93M	USD	1 Quarter
Research and development	`ResearchAndDevelopmentExpense`	$25.79M	USD	1 Quarter
Research and development	`ResearchAndDevelopmentExpense`	$29.02M	USD	1 Quarter
Income from operations	`OperatingIncomeLoss`	$113.04M	USD	1 Quarter
Income from operations	`OperatingIncomeLoss`	$92.24M	USD	1 Quarter
Interest expense	`InterestExpense`	$8.59M	USD	1 Quarter
Interest expense	`InterestExpense`	$9.27M	USD	1 Quarter
Interest income	`InterestAndOtherIncome`	$1.08M	USD	1 Quarter
Interest income	`InterestAndOtherIncome`	$579.00K	USD	1 Quarter
Income before provision for income taxes	`IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments`	$84.74M	USD	1 Quarter
Income before provision for income taxes	`IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments`	$104.35M	USD	1 Quarter
Provision for income taxes	`IncomeTaxExpenseBenefit`	$15.68M	USD	1 Quarter
Provision for income taxes	`IncomeTaxExpenseBenefit`	$14.87M	USD	1 Quarter
Net income	`ProfitLoss`	$89.48M	USD	1 Quarter
Net income	`ProfitLoss`	$69.06M	USD	1 Quarter
Less: Net income attributable to noncontrolling interest	`NetIncomeLossAttributableToNoncontrollingInterest`	$25.00K	USD	1 Quarter
Less: Net income attributable to noncontrolling interest	`NetIncomeLossAttributableToNoncontrollingInterest`	$39.00K	USD	1 Quarter
Net income attributable to IDEXX Laboratories, Inc. stockholders	`NetIncomeLoss`	$69.02M	USD	1 Quarter
Net income attributable to IDEXX Laboratories, Inc. stockholders	`NetIncomeLoss`	$89.45M	USD	1 Quarter
Basic	`EarningsPerShareBasic`	$1.02	USD	1 Quarter
Basic	`EarningsPerShareBasic`	$0.78	USD	1 Quarter
Diluted	`EarningsPerShareDiluted`	$0.77	USD	1 Quarter
Diluted	`EarningsPerShareDiluted`	$1.01	USD	1 Quarter
Basic	`WeightedAverageNumberOfSharesOutstandingBasic`	88.12M	shares	1 Quarter
Basic	`WeightedAverageNumberOfSharesOutstandingBasic`	87.33M	shares	1 Quarter
Diluted	`WeightedAverageNumberOfDilutedSharesOutstanding`	89.99M	shares	1 Quarter
Diluted	`WeightedAverageNumberOfDilutedSharesOutstanding`	88.94M	shares	1 Quarter

Cash Flow Statement 53 line items

Line Item	Tag	Value	Unit	Period
Net income	`ProfitLoss`	$89.48M	USD	1 Quarter
Net income	`ProfitLoss`	$69.06M	USD	1 Quarter
Depreciation and amortization	`DepreciationDepletionAndAmortization`	$20.80M	USD	1 Quarter
Depreciation and amortization	`DepreciationDepletionAndAmortization`	$20.31M	USD	1 Quarter
Benefit of deferred income taxes	`DeferredIncomeTaxExpenseBenefit`	$3.00M	USD	1 Quarter
Benefit of deferred income taxes	`DeferredIncomeTaxExpenseBenefit`	$1.94M	USD	1 Quarter
Share-based compensation expense	`ShareBasedCompensation`	$5.66M	USD	1 Quarter
Share-based compensation expense	`ShareBasedCompensation`	$5.96M	USD	1 Quarter
Other	`OtherOperatingActivitiesCashFlowStatement`	$1.09M	USD	1 Quarter
Other	`OtherOperatingActivitiesCashFlowStatement`	$860.00K	USD	1 Quarter
Accounts receivable	`IncreaseDecreaseInAccountsReceivable`	$19.43M	USD	1 Quarter
Accounts receivable	`IncreaseDecreaseInAccountsReceivable`	$21.80M	USD	1 Quarter
Inventories	`IncreaseDecreaseInInventories`	$5.37M	USD	1 Quarter
Inventories	`IncreaseDecreaseInInventories`	$8.07M	USD	1 Quarter
Other assets and liabilities	`IncreaseDecreaseInOtherOperatingCapitalNet`	$52.30M	USD	1 Quarter
Other assets and liabilities	`IncreaseDecreaseInOtherOperatingCapitalNet`	$38.53M	USD	1 Quarter
Accounts payable	`IncreaseDecreaseInAccountsPayableTrade`	$-1.94M	USD	1 Quarter
Accounts payable	`IncreaseDecreaseInAccountsPayableTrade`	$-3.69M	USD	1 Quarter
Deferred revenue	`IncreaseDecreaseInDeferredRevenue`	$469.00K	USD	1 Quarter
Deferred revenue	`IncreaseDecreaseInDeferredRevenue`	$-1.33M	USD	1 Quarter
Net cash provided by operating activities	`NetCashProvidedByUsedInOperatingActivities`	$34.90M	USD	1 Quarter
Net cash provided by operating activities	`NetCashProvidedByUsedInOperatingActivities`	$31.27M	USD	1 Quarter
Purchases of property and equipment	`PaymentsToAcquirePropertyPlantAndEquipment`	$23.73M	USD	1 Quarter
Purchases of property and equipment	`PaymentsToAcquirePropertyPlantAndEquipment`	$23.65M	USD	1 Quarter
Purchase of marketable securities	`PaymentsToAcquireAvailableForSaleSecuritiesDebt`	$90.49M	USD	1 Quarter
Purchase of marketable securities	`PaymentsToAcquireAvailableForSaleSecuritiesDebt`	$87.00K	USD	1 Quarter
Proceeds from the sale and maturities of marketable securities	`ProceedsFromSaleOfAvailableForSaleSecuritiesDebt`	$87.48M	USD	1 Quarter
Proceeds from the sale and maturities of marketable securities	`ProceedsFromSaleOfAvailableForSaleSecuritiesDebt`	$284.12M	USD	1 Quarter
Acquisitions of a business, net of cash acquired	`PaymentsToAcquireBusinessesNetOfCashAcquired`	$2.35M	USD	1 Quarter
Net cash provided (used) by investing activities	`NetCashProvidedByUsedInInvestingActivities`	$260.31M	USD	1 Quarter
Net cash provided (used) by investing activities	`NetCashProvidedByUsedInInvestingActivities`	$-29.01M	USD	1 Quarter
(Repayments) borrowings on revolving credit facilities, net	`ProceedsFromRepaymentsOfOtherDebt`	$-247.50M	USD	1 Quarter
(Repayments) borrowings on revolving credit facilities, net	`ProceedsFromRepaymentsOfOtherDebt`	$60.00M	USD	1 Quarter
Repurchases of common stock	`PaymentsForRepurchaseOfCommonStock`	$63.91M	USD	1 Quarter
Repurchases of common stock	`PaymentsForRepurchaseOfCommonStock`	$83.49M	USD	1 Quarter
Proceeds from exercises of stock options and employee stock purchase plans	`ProceedsFromIssuanceOfSharesUnderIncentiveAndShareBasedCompensationPlansIncludingStockOptions`	$14.55M	USD	1 Quarter
Proceeds from exercises of stock options and employee stock purchase plans	`ProceedsFromIssuanceOfSharesUnderIncentiveAndShareBasedCompensationPlansIncludingStockOptions`	$12.53M	USD	1 Quarter
Shares withheld for statutory tax withholding on restricted stock	`PaymentsRelatedToTaxWithholdingForShareBasedCompensation`	$7.30M	USD	1 Quarter
Shares withheld for statutory tax withholding on restricted stock	`PaymentsRelatedToTaxWithholdingForShareBasedCompensation`	$8.55M	USD	1 Quarter
Net cash (used) provided by financing activities	`NetCashProvidedByUsedInFinancingActivities`	$-324.99M	USD	1 Quarter
Net cash (used) provided by financing activities	`NetCashProvidedByUsedInFinancingActivities`	$1.31M	USD	1 Quarter
Net effect of changes in exchange rates on cash	`EffectOfExchangeRateOnCashAndCashEquivalents`	$1.93M	USD	1 Quarter
Net effect of changes in exchange rates on cash	`EffectOfExchangeRateOnCashAndCashEquivalents`	$1.33M	USD	1 Quarter
Net (decrease) increase in cash and cash equivalents	`CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect`	$-28.45M	USD	1 Quarter
Net (decrease) increase in cash and cash equivalents	`CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect`	$5.51M	USD	1 Quarter
Cash and cash equivalents at beginning of period	`CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents`	$159.23M	USD	Point-in-time
Cash and cash equivalents at beginning of period	`CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents`	$154.90M	USD	Point-in-time
Cash and cash equivalents at beginning of period	`CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents`	$160.41M	USD	Point-in-time
Cash and cash equivalents at beginning of period	`CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents`	$187.68M	USD	Point-in-time
Cash and cash equivalents at end of period	`CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents`	$159.23M	USD	Point-in-time
Cash and cash equivalents at end of period	`CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents`	$154.90M	USD	Point-in-time
Cash and cash equivalents at end of period	`CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents`	$160.41M	USD	Point-in-time
Cash and cash equivalents at end of period	`CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents`	$187.68M	USD	Point-in-time

Comprehensive Income 28 line items

Line Item	Tag	Value	Unit	Period
Unrealized gain (loss) on investments, tax expense (benefit)	`OtherComprehensiveIncomeLossAvailableForSaleSecuritiesTax`	$-26.00K	USD	1 Quarter
Net income	`ProfitLoss`	$89.48M	USD	1 Quarter
Unrealized gain (loss) on investments, tax expense (benefit)	`OtherComprehensiveIncomeLossAvailableForSaleSecuritiesTax`	$40.00K	USD	1 Quarter
Net income	`ProfitLoss`	$69.06M	USD	1 Quarter
Unrealized loss, tax (benefit) expense	`OtherComprehensiveIncomeUnrealizedGainLossOnDerivativesArisingDuringPeriodTax`	$-377.00K	USD	1 Quarter
Unrealized loss, tax (benefit) expense	`OtherComprehensiveIncomeUnrealizedGainLossOnDerivativesArisingDuringPeriodTax`	$-912.00K	USD	1 Quarter
Foreign currency translation adjustments	`OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax`	$5.17M	USD	1 Quarter
Reclassification adjustment for loss (gains) included in net income, tax (benefit) expense	`OtherComprehensiveIncomeLossReclassificationAdjustmentFromAOCIOnDerivativesTax`	$250.00K	USD	1 Quarter
Foreign currency translation adjustments	`OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax`	$8.01M	USD	1 Quarter
Reclassification adjustment for loss (gains) included in net income, tax (benefit) expense	`OtherComprehensiveIncomeLossReclassificationAdjustmentFromAOCIOnDerivativesTax`	$-401.00K	USD	1 Quarter
Unrealized loss on net investment hedge	`TranslationAdjustmentForNetInvestmentHedgeIncreaseDecreaseNetOfTax`	$-1.09M	USD	1 Quarter
Unrealized loss on net investment hedge	`TranslationAdjustmentForNetInvestmentHedgeIncreaseDecreaseNetOfTax`	$-2.22M	USD	1 Quarter
Unrealized gain (loss) on investments, net of tax expense (benefit) of $40 in 2018 and $(26) in 2017	`OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodNetOfTax`	$118.00K	USD	1 Quarter
Unrealized gain (loss) on investments, net of tax expense (benefit) of $40 in 2018 and $(26) in 2017	`OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodNetOfTax`	$-39.00K	USD	1 Quarter
Unrealized loss, net of tax (benefit) of $(377) in 2018 and $(912) in 2017	`OtherComprehensiveIncomeUnrealizedGainLossOnDerivativesArisingDuringPeriodNetOfTax`	$-1.53M	USD	1 Quarter
Unrealized loss, net of tax (benefit) of $(377) in 2018 and $(912) in 2017	`OtherComprehensiveIncomeUnrealizedGainLossOnDerivativesArisingDuringPeriodNetOfTax`	$-2.39M	USD	1 Quarter
Reclassification adjustment for losses (gains) included in net income, net of tax (benefit) expense of $(250) in 2018 and $401 in 2017	`OtherComprehensiveIncomeLossReclassificationAdjustmentFromAOCIOnDerivativesNetOfTax`	$-1.58M	USD	1 Quarter
Reclassification adjustment for losses (gains) included in net income, net of tax (benefit) expense of $(250) in 2018 and $401 in 2017	`OtherComprehensiveIncomeLossReclassificationAdjustmentFromAOCIOnDerivativesNetOfTax`	$674.00K	USD	1 Quarter
Unrealized loss on derivative instruments	`OtherComprehensiveIncomeLossDerivativesQualifyingAsHedgesNetOfTax`	$-803.00K	USD	1 Quarter
Unrealized loss on derivative instruments	`OtherComprehensiveIncomeLossDerivativesQualifyingAsHedgesNetOfTax`	$-2.21M	USD	1 Quarter
Other comprehensive gain, net of tax	`OtherComprehensiveIncomeLossNetOfTax`	$4.67M	USD	1 Quarter
Other comprehensive gain, net of tax	`OtherComprehensiveIncomeLossNetOfTax`	$2.26M	USD	1 Quarter
Comprehensive income	`ComprehensiveIncomeNetOfTaxIncludingPortionAttributableToNoncontrollingInterest`	$73.73M	USD	1 Quarter
Comprehensive income	`ComprehensiveIncomeNetOfTaxIncludingPortionAttributableToNoncontrollingInterest`	$91.74M	USD	1 Quarter
Less: comprehensive income attributable to noncontrolling interest	`ComprehensiveIncomeNetOfTaxAttributableToNoncontrollingInterest`	$25.00K	USD	1 Quarter
Less: comprehensive income attributable to noncontrolling interest	`ComprehensiveIncomeNetOfTaxAttributableToNoncontrollingInterest`	$39.00K	USD	1 Quarter
Comprehensive income attributable to IDEXX Laboratories, Inc.	`ComprehensiveIncomeNetOfTax`	$73.69M	USD	1 Quarter
Comprehensive income attributable to IDEXX Laboratories, Inc.	`ComprehensiveIncomeNetOfTax`	$91.72M	USD	1 Quarter

Data is extracted from SEC EDGAR XBRL filings. Values shown are as reported in the filing.